Siamak Daneshmand, Daniel Canter, Tracey Lynn Krupski, Daniel A. Shoskes, Daniel Armandi, Neal D. Shore. "ABLE-41, a real-world evidence study for bladder cancer patients treated with nadofaragene firadenovec: Baseline patient characteristics and demographics.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16608